Document is current
Any future updates will be listed below
-
Authors
Blyth, Rhianna R. R.
Laversin, Stèphanie A.
Foxall, Russell B.
Savva, Constantinos
Copson, Ellen
Cutress, Ramsey I.
Birts, Charles N.
Beers, Stephen A.
-
Funding
Funding for this research was provided by:
Cancer Research UK
Breast Cancer Now
Against Breast Cancer
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 15 May 2025
First Online: 30 May 2025
Competing interests
: The authors declare that they have no competing interests, with the exception of E.C., who declares honorarium from Astra-Zeneca, Daaichi-Sankyo, Eli-Lilly, Novartis, Pfizer, Roche; advisory board/consultancy for Astra-Zeneca, Eli-Lilly, Nanostring, Novartis, Pfizer; conference fees/travel/ accommodation from Roche, Novartis; educational grant from Daiichi-Sankyo and research support/funding from SECA, Astra-Zeneca, and R.I.C., who declares institutional research support/funding from SECA and Astra-Zeneca.
